Amicas Plans $39M Buyout of Emageon
Amicas (NASDAQ:AMCS), a Boston-based provider of software for managing medical images and other healthcare information, says that it has agreed to buy competitor Emageon (NASDAQ:EMAG), headquartered in Birmingham, AL, for $39 million in cash. Emageon’s board of directors has approved the deal, and Amicas plans March 5 to begin a tender offer of $1.82 per share to acquire all outstanding shares of Emageon common stock. News of the deal sent Emageon shares up 93 cents, or 124 percent, as of 4 p.m. ET.